Planta Med 2014; 80(11): 896-901
DOI: 10.1055/s-0034-1382836
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Purification and Characterization of a Novel Type I Ribosome Inactivating Protein, Pachyerosin, from Pachyrhizus erosus Seeds, and Preparation of its Immunotoxin against Human Hepatoma Cells

Jin-Lin Guo
1   Key Laboratory of Standardization of Chinese Medicine, Ministry of Education, Chengdu University of Traditional Chinese Medicine, Chengdu, China
2   LuzhouLaoJiao Co., Ltd., Luzhou, China
,
Yuan-Liu Cheng
1   Key Laboratory of Standardization of Chinese Medicine, Ministry of Education, Chengdu University of Traditional Chinese Medicine, Chengdu, China
,
Yi Qiu
1   Key Laboratory of Standardization of Chinese Medicine, Ministry of Education, Chengdu University of Traditional Chinese Medicine, Chengdu, China
,
Cai-Hong Shen
2   LuzhouLaoJiao Co., Ltd., Luzhou, China
,
Bin Yi
2   LuzhouLaoJiao Co., Ltd., Luzhou, China
,
Cheng Peng
1   Key Laboratory of Standardization of Chinese Medicine, Ministry of Education, Chengdu University of Traditional Chinese Medicine, Chengdu, China
› Author Affiliations
Further Information

Publication History

received 04 February 2014
revised 24 May 2014

accepted 04 June 2014

Publication Date:
16 July 2014 (online)

Abstract

Pachyrhizus erosus seeds have a high protein content and are used in China due to their cytotoxic effect. Here we report the biological and pharmacological activity of the protein extracts from P. erosus seeds. A novel ribosome-inactivating protein, pachyerosin, from P. erosus seeds was successively purified to homogeneity using ammonium sulfate precipitation, DEAE-sepharose FF, and Sephacryl S-200. Pachyerosin showed to be a type I ribosome-inactivating protein with a molecular mass of 29 kDa and an isoelectric point of 9.19. It strongly inhibited protein synthesis of rabbit reticulocyte lysate with an IC50 of 0.37 ng/mL and showed N-glycosidase activity on rat liver ribosomes with an EC50 of 85.9 pM. The N-terminal 27 amino acids of pachyerosin revealed a 60.71 % sequence identity with abrin A from the seeds of Abrus precatorius. With the aim of targeting the delivery of pachyerosin, immunotoxin was prepared by conjugating pachyerosin with anti-human AFP monoclonal antibodies SM0736. The immunotoxin pachyerosin-SM0736 efficiently inhibited the growth of the human hepatoma cell line HuH-7 with an IC50 of 0.050 ± 0.004 nM, 2360 times lower than that of pachyerosin and 430 times lower than that of the immunotoxin against human gastric cancer cell line SGC7901. These results imply that pachyerosin may be used as a new promising anticancer agent.

 
  • References

  • 1 Ng NQ. Conserving tropical leguminous food crops. In: Normah MN, Chin HF, Reed BM, editors Conservation of tropical plant species. New York: Springer; 2013: 213-247
  • 2 Jian Z. Research report on history of Yam Beanʼs cultivation and spread. Anc Mod Agric 2007; 3: 40-48
  • 3 Noman ASM, Hoque MA, Sen PK, Karim MR. Purification and some properties of α-amylase from post-harvest Pachyrhizus erosus L. tuber. Food Chem 2006; 99: 444-449
  • 4 Fernandez MV, Warid WA, Loaiza JM, Agustin MC. Developmental patterns of jicama (Pachyrhizus erosus (L.) Urban) plant and the chemical constituents of roots grown in Sonora, Mexico. Plant Foods Hum Nutr 1997; 50: 279-286
  • 5 Lautié E, Rozet E, Hubert P, Vandelaer N, Billard F, zum Felde T, Grüneberg WJ, Quetin-Leclercq J. Fast method for the simultaneous quantification of toxic polyphenols applied to the selection of genotypes of yam bean (Pachyrhizus sp.) seeds. Talanta 2013; 117: 94-101
  • 6 Xie ZW, Fan CS, Zhu ZY. The collection of Chinese traditional and herbal drugs. 2nd. edition. Beijing: The Peopleʼs Health Publishing House; 1996: 853-855
  • 7 Grüneberg WJ, Goffman FD, Velasco L. Characterization of yam bean (Pachyrhizus spp.) seeds as potential sources of high palmitic acid oil. J Am Oil Chem Soc 1999; 76: 1309-1312
  • 8 Kondo T, Kurihara S, Yoshikawa T, Mizukami H. Effect of N-and C-terminal deletions on the RNA N-glycosidase activity and the antigenicity of karasurin-A, a ribosome-inactivating protein from Trichosanthes kirilowii var. japonica . Biotechnol Lett 2004; 26: 1873-1878
  • 9 Reyes AG, Anné J, Mejía A. Ribosome-inactivating proteins with an emphasis on bacterial RIPs and their potential medical applications. Future Microbiol 2012; 7: 705-717
  • 10 Kaur I, Yadav SK, Hariprasad G, Gupta RC, Srinivasan A, Batra JK, Puri M. Balsamin, a novel ribosome-inactivating protein from the seeds of Balsam apple Momordica balsamina . Amino Acids 2012; 43: 973-981
  • 11 Balconi C, Lanzanova C, Motto M. Ribosome-inactivating proteins in cereals. In: Lord J, Hartley MR, editors Toxic plant proteins. Berlin, Heidelberg: Springer; 2010: 149-166
  • 12 Puri M, Kaur I, Perugini MA, Gupta RC. Ribosome-inactivating proteins: current status and biomedical applications. Drug Discov Today 2012; 17: 774-783
  • 13 Dosio F, Brusa P, Cattel L. Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components. Toxins 2011; 3: 848-883
  • 14 Li Z, Qu Y, Li H, Yuan J. Truncations of gelonin lead to a reduction in its cytotoxicity. Toxicology 2007; 231: 129-136
  • 15 Wood KA, Lord JM, Wawrzynczak EJ, Piatak M. Preproabrin: genomic cloning, characterisation and the expression of the A-chain in Escherichia coli . Eur J Biochem 1991; 198: 723-732
  • 16 Halling KC, Halling AC, Murray EE, Ladin BF, Houston LL, Weaver RF. Genomic cloning and characterization of a ricin gene from Ricinus communis . Nucleic Acids Res 1985; 13: 8019-8033
  • 17 Collins EJ, Robertus JD, LoPresti M, Stone KL, Williams KR, Wu P, Piatak M. Primary amino acid sequence of alpha-trichosanthin and molecular models for abrin A-chain and alpha-trichosanthin. J Biol Chem 1990; 265: 8665-8669
  • 18 Islam MR, Hirayama H, Funatsu G. Complete amino acid sequence of luffin-b, a ribosome-inactivating protein from sponge gourd (Luffa cylindrica) seeds. Agric Biol Chem 1991; 55: 229-238
  • 19 Kondo T, Yoshikawa T. Purification and characterization of abelesculin, a novel ribosome-inactivating protein from the mature seeds of Abelmoschus esculentus . J Nat Med 2007; 61: 170-174
  • 20 Silva AL, Goto LS, Dinarte AR, Hansen D, Moreira RA, Beltramini LM, Araújo AP. Pulchellin, a highly toxic type 2 ribosome-inactivating protein from Abrus pulchellus . FEBS J 2005; 272: 1201-1210
  • 21 Ferreras JM, Citores L, Iglesias R, Jiménez P, Girbés T. Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy. Toxins 2011; 3: 420-441
  • 22 Aruna G. Immunotoxins: a review of their use in cancer treatment. JSRM 2006; 1: 31-36
  • 23 Becker N, Benhar I. Antibody-based immunotoxins for the treatment of cancer. Antibodies 2012; 1: 39-69
  • 24 Yoshinari S, Yokota S, Sawamoto H, Koresawa S, Tamura M, Endo Y. Purification, characterization and subcellular localization of a type-1 ribosome-inactivating protein from the sarcocarp of Cucurbita pepo . Eur J Biochem 1996; 242: 585-591
  • 25 Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. J Biol Chem 1987; 262: 5908-5912
  • 26 Wang QC, Ying WB, Xie H, Zhang ZC, Yang ZH, Ling LQ. Trichosanthin-monoclonal antibody conjugate specifically cytotoxic to human hepatoma cells in vitro . Cancer Res 1991; 51: 3353-3355
  • 27 Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63